Similar articles

• Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.

  Janols LO, Liliemark J, Klintberg K, von Knorring AL. Janols LO, et al. Nord J Psychiatry. 2009 Nov;63(6):508-16. doi: 10.3109/08039480903154534. Nord J Psychiatry. 2009. PMID: 19958258
• Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.

  Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B. Cox DJ, et al. Pediatrics. 2006 Sep;118(3):e704-10. doi: 10.1542/peds.2005-2947. Pediatrics. 2006. PMID: 16950962 Clinical Trial.
• A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.

  Varley CK. Varley CK. Psychopharmacol Bull. 1985;21(2):216-21. Psychopharmacol Bull. 1985. PMID: 2860692 Review. No abstract available.
• Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.

  Gadow KD, Sverd J. Gadow KD, et al. Adv Neurol. 2006;99:197-207. Adv Neurol. 2006. PMID: 16536367 Review. No abstract available.
• Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.

  Marcus SC, Durkin M. Marcus SC, et al. J Am Acad Child Adolesc Psychiatry. 2011 May;50(5):480-9. doi: 10.1016/j.jaac.2011.02.007. Epub 2011 Apr 7. J Am Acad Child Adolesc Psychiatry. 2011. PMID: 21515197